GlassScriptPhysician profile
Timothy S Petsche
NPI 1124099809
$6,546.11
in general payments reported to CMS, 2019-2025
13 companies · $4,230 in 2025
The $4,230 reported for 2025 was more than what 79% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,521 · 2020: $115 · 2021: $24.39 · 2022: $23.81 · 2023: $289 · 2024: $343 · 2025: $4,230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Food and Beverage | $862.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Miach Orthopaedics, INC. | $4,409.24 | 2024-2025 | |
| Arthrex, INC. | $1,097.57 | 2019 | |
| Medwest Associates | $370.00 | 2019 | |
| Vericel Corporation | $201.57 | 2021-2025 | Maci |
| Horizon Therapeutics Plc | $101.92 | 2023 | Krystexxa |
| Terumo Bct, INC. | $95.55 | 2020 | |
| Stryker Corporation | $67.44 | 2023-2024 | Citrefix, Axs Infinity Ls |
| Smith+Nephew, INC. | $57.54 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $41.14 | 2024 | Exparel, Zilretta, Iovera |
| Lightbody Medical Technologies INC | $35.71 | 2023 | |
| Amgen INC. | $29.80 | 2025 | Evenity |
| Orthofix Medical, INC. | $23.81 | 2022 | |
| Radius Health, INC. | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Petsche listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.